ACTD: BRIDGE BETWEEN REGULATORY REQUIREMENTS OF DEVELOPED AND DEVELOPING COUNTRIES
Journal Title: International Journal of Drug Regulatory Affairs - Year 2013, Vol 1, Issue 4
Abstract
Regulatory Dossier contains data which when submitted to the regulatory authority, provides for the review and ultimate approval of a drug product. Once approved, an applicant may manufacture and market the drug to provide a safe, effective and low cost which benefits the society. Filing requirements in developed countries differ from developing countries which makes the approval process tedious and time consuming for the later. To make this process smooth, ASEAN CTD (ACTD) was developed by Association of South East Asian Nations (ASEAN) nations. As format of ACTD resembles the format of Common Technical Document (CTD) with some differences, hence it can be used as a step. Also if both guidelines can be harmonized then differences and variation between both the guidelines can be minimized. This article focuses on the similarities and differences in between CTD & ACTD and highlights how ACTD can be a initiating step for developing countries to meet pharmaceutical regulations of developed countries.
Authors and Affiliations
Jain Achin, Venkatesh M P, Pramod Kumar T M
Keywords
Related Articles
- EP ID EP338247
- DOI -
- Views 123
- Downloads 0
FORMULATION, DEVELOPMENT AND OPTIMIZATION OF MODIFIED RELEASING PELLETS OF DRUG CARVEDILOL
The main objectives of present work was to design and evaluate modified releasing pellets of drug, Carvedilol, in respect to increase patient compliance and therapeutically benefits. The modified releasing pellets were m...
RISK DRIVERS OF FALSIFIED AND SUB-STANDARD MEDICINES IN EAST AFRICA: PERCEPTIONS AND PRACTICES OF PHARMACEUTICAL DRUG FACILITY OWNERS/EMPLOYEES
An interview survey was conducted among drug shop owners to investigate the access to and perception of counterfeit medication along transport corridors of East Africa spanning Kenya, Tanzania, Uganda and Democratic Repu...
Regulatory requirements for Drug master file in context to Canada and Australia
Drug Master Files are required in most countries as supporting documents for the registration of drug products. DMFs generally contain information pertaining to the chemistry, manufacturing and controls (CMC) sections of...
REGULATIONS OF ORPHAN DRUGS IN USA, EU AND INDIA-A COMPARATIVE STUDY
Orphan drugs are the drugs and natural products used in treatment, diagnosis, or prevention of rare disease. The orphan drug regulation varies in different countries. Initially a guideline (Orphan Drug Act) for orphan dr...
DRUG APPROVAL PROCESS: A CONTRASTIVE APPROACH
The drug approval process is the vehicle through which drug sponsors formally approve a new pharmaceutical for sale and marketing. The goals of the approval process are to provide enough information about the drug safety...